Regulatory update: The Saudi government has notified registered users of the goverment's drug track and trace system (RSD) that the deadline for aggregation of medicines is now August 20, 2020.
In early 2019, the Saudi Food and Drug Authority (SFDA) initiated reporting requirements that affect all companies producing medicines for the Saudi Arabia market. Manufacturers need to understand how they can comply immediately with SFDA regulations—and prepare for aggregation in October 2019. How do they register with SFDA? What operations will need to be reported to the Saudi track-and-trace system? How will trade partners exchange information as products move through the Saudi supply chain?
In this on-demand webinar, Solutions Consultant Ayman Waneis and Industry Marketing Director Allan Bowyer provide a detailed overview of the business and operational challenges companies face in the Saudi Arabia market—and how TraceLink supports a comprehensive approach to SFDA compliance.
You will learn about:
- Saudi Arabia requirements
- Planning for Saudi Arabia aggregation
- Challenges in post-manufacturing serialization
- TraceLink Saudi Arabia solution platform
Register today and start getting ready for Saudi Arabia compliance.